VISHWA JEET AMATYA
Last Updated :2024/04/03
- Affiliations, Positions
- Graduate School of Biomedical and Health Sciences(Medicine), Associate Professor or Lecturer
- Web Site
- E-mail
- amatyahiroshima-u.ac.jp
- Other Contact Details
- Department of Pathology
Hiroshima University
Graduate School of Biomedical & Health Sciences
1-2-3 Kasumi, Minami-ku, Hiroshima
JAPAN
734-8551, Japan
TEL : (+81)82-257-5152 FAX : (+81)82-257-5154
- Self-introduction
- Working in Department of Pathology, Hiroshima University Graduate School of Biomedical & Health Sciences.
My research interest is to understand the diagnostic approach and its biology of malignant mesothelioma.
Basic Information
Major Professional Backgrounds
- 2019/04/01, Hiroshima University Graduate School of Biomedical & Health Sciences, Department of Pathology, Lecturer
- 2012/10/01, 2019/03/31, Hiroshima University Institute of Biomedical & Health Sciences, Department of Pathology, Lecturer
- 2007/04/01, 2012/09/31, Hiroshima University Graduate School of Biomedical Sciences, Department of Pathology, Assistant Professor
- 2005/05/01, 2007/03/31, Hiroshima University Graduate School of Biomedical Sciences, Department of Pathology, Research Assistant
- 2003/11/01, 2005/04/30, International Agency for Research on Cancer, WHO, LYON, Molecular Pathology, Post Doctoral Fellow
- 2003/08/01, 2003/10/30, Nepal Medical College, Kathmandu, NEPAL, Department of Pathology, Lecturer
Educational Backgrounds
- Hiroshima University, Graduate School of Medicine, PhD (Medicine), Japan, 1999/04, 2003/03
- Hiroshima University, Graduate School of Medicine, Foreign Researcher [Neuropathology], Japan, 1997/10, 1999/03
- Tribhuvan University, Institute of Medicine, MD [Pathology], Nepal, 1995/04, 1997/09
- Gorakhpur University, BRD Medical College, MBBS, INDIA, 1987/09, 1992/08
Academic Degrees
- PhD [Medicine], Hiroshima University
- MBBS, BRD Medical College, Gorakhpur University, INDIA
Educational Activity
- [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
- [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
- [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
- [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine
In Charge of Primary Major Programs
Research Fields
- Medicine,dentistry, and pharmacy;Basic medicine;Human pathology
- Medicine,dentistry, and pharmacy;Basic medicine;Experimental pathology
Research Keywords
- Mesothelioma
- Lung Cancer
- Asbestos Related Lung Cancer
- Comprehensive Gene Expression Analysis
- MiRNA Expression & Functional Analysis
- Brain Tumor Pathology
Affiliated Academic Societies
- The International Association for the Study of Lung Cancer (IASLC), 2017
- The Japan Lung Cancer Society, 2005
- Japan Asbestos・Mesothelioma Study Group, 2005
- The Japan Society of Brain Tumor Pathology, 2001
- The Japanese Cancer Association, 2000
- The Japanese Society of Pathology, 1999
- Nepal Medical Association, 1992
Educational Activity
Course in Charge
- 2024, Liberal Arts Education Program1, 2Term, Peace Messages from "Kasumi Campus"
- 2024, Undergraduate Education, Second Semester, Clinical Pathology
- 2024, Undergraduate Education, Intensive, Practice of Medicine I
- 2024, Undergraduate Education, First Semester, General Pathology
- 2024, Undergraduate Education, First Semester, Pathology
- 2024, Undergraduate Education, First Semester, Pathology
- 2024, Undergraduate Education, Intensive, Pathology
- 2024, Undergraduate Education, First Semester, Outline of Pathology
- 2024, Graduate Education (Master's Program) , First Semester, Seminar
- 2024, Graduate Education (Master's Program) , Second Semester, Seminar
- 2024, Graduate Education (Master's Program) , First Semester, Research
- 2024, Graduate Education (Master's Program) , Second Semester, Research
- 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar
- 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar
- 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research
- 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research
- 2024, Graduate Education (Master's Program) , Second Semester, Pathologic Basis of Diseases
- 2024, Graduate Education (Master's Program) , 1Term, Methods in Biomedical Sciences A
- 2024, Graduate Education (Doctoral Program) , 3Term, Creation and Development of Biomedical Sciences
- 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Pathology
- 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Pathology
- 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Pathology
- 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Pathology
Research Activities
Academic Papers
- A case of malignant fibrous histiocytoma of the petrous bone present-ing with facial nerve palsy, JAPANESE JOURNAL OF NEUROSURGERY, 22(4), 306-312, 201304
- A case of papillary glioneuronal tumor, JAPANESE JOURNAL OF NEUROSURGERY, 22(11), 860-865, 201301
- A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases, AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 130(5), 771-779, 200811
- Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma., ONCOLOGY REPORTS, 24(2), 423-431, 201008
- Accuracy of pathological diagnosis of mesothelioma cases in Japan: Clinicopathological analysis of 382 cases, LUNG CANCER, 66(2), 191-197, 200911
- Advantage of high b value diffusion -weighted imaging for differentiation of common pediatric brain tumors in posterior fossa, EUROPEAN JOURNAL OF RADIOLOGY, 128(108983), 202007
- Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement, BRAIN PATHOLOGY, 28(5), 684-694, 201809
- Benign fibrous histiocytoma arising at the temporal bone of an infant - case report and review of the literature., CHILDS NERVOUS SYSTEM, 32(1), 189-193, 201601
- CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma, CLINICAL CANCER RESEARCH, 18(5), 1447-1456, 201203
- CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma., ONCOLOGY REPORTS, 29(1), 21-28, 201301
- Case of clear cell ependymoma of medulla oblongata: Clinicopathological and immunohistochemical study with literature review, PATHOLOGY INTERNATIONAL, 53(5), 297-302, 200305
- Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, HISTOPATHOLOGY, 55(1), 10-19, 200907
- Characteristics and therapeutic strategies of brain and cranial radiation-induced sarcoma: analysis of 165 cases from our case experience and comprehensive review, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53(10), 905-911, 202310
- Characteristics and therapeutic strategies of radiation-induced glioma: case series and comprehensive literature review, JOURNAL OF NEURO-ONCOLOGY, 159(3), 531-538, 202209
- Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: Comparative study with 11 pilocytic astrocytomas, PATHOLOGY INTERNATIONAL, 59(2), 80-85, 200902
- Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress, PATHOLOGY INTERNATIONAL, 70(12), 943-952, 202012
- Co-existent carcinosarcoma and adenoid basal carcinoma of the uterine cervix and correlation with human papillomavirus infection, INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 21(2), 186-190, 200204
- Coexistence of gastrointestinal stromal tumor and leiomyosarcoma of the stomach presenting as a collision tumor: A case report and review of literature, PATHOLOGY INTERNATIONAL, 68(5), 313-317, 201805
- Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone, JOURNAL OF NEUROSURGERY, 110(2), 369-373, 200902
- Concurrent Schwannoma and Meningioma Arising in the Same Spinal Level: A Report of Two Cases, NMC CASE REPORT JOURNAL, 5(4), 105-109, 201809
- Desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia., INTERNATIONAL CANCER CONFERENCE JOURNAL, 2(3), 178-182, 201307
- Detecting non-germinomatous germ cell tumor component by arterial spin labeling perfusion-weighted MR imaging in central nervous system germ cell tumor, EUROPEAN JOURNAL OF RADIOLOGY, 136, 202103
- Differences in invasiveness and recurrence rate among nonfunctioning pituitary neuroendocrine tumors depending on tumor subtype, NEUROSURGICAL REVIEW, 46(1), 202311
- Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry, PATHOLOGY INTERNATIONAL, 58(2), 75-83, 200802
- Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma, INTERNATIONAL JOURNAL OF ONCOLOGY, 48(4), 1599-1607, 201604
- Diffuse leptomeningeal glioneuronal tumor (DLGNT) mimicking Whipple's disease: a case report and literature review, CHILDS NERVOUS SYSTEM, 33(8), 1411-1414, 201708
- Diffusion-weighted imaging-gadolinium enhancement mismatch sign in diffuse midline glioma, EUROPEAN JOURNAL OF RADIOLOGY, 147, 202202
- Downregulation of FTL decreases proliferation of malignant mesothelioma cells by inducing G(1) cell cycle arrest, ONCOLOGY LETTERS, 23(6), 174, 202206
- Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1, ONCOLOGY REPORTS, 47(2), 27, 202202
- Dysplastic glioneuronal lesion arising in the cerebellum: a clinicopathological, immunohistochemical and ultrastructural study, CLINICAL NEUROPATHOLOGY, 20(2), 73-79, 200103
- Effect of bevacizumab against cystic components of brain tumors, CANCER MEDICINE, 8(15), 6519-6527, 201911
- Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation, PATHOLOGY INTERNATIONAL, 54(10), 803-809, 200410
- Evaluation of Apoptosis and Immunohistochemical Expression of the Apoptosis-related Proteins in Mesothelioma, HIROSHIMA JOURNAL OF MEDICAL SCIENCES, 59(2), 27-33, 201006
- Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast, PATHOLOGY INTERNATIONAL, 56(5), 256-261, 200605
- FOXM1 Promotes Mesothelioma Cell Migration and Invasion via Activation of SMAD Signaling, ANTICANCER RESEARCH, 43(9), 3961-3968, 202309
- Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient at MR imaging, EUROPEAN JOURNAL OF RADIOLOGY, 73(3), 532-537, 201003
- Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, MODERN PATHOLOGY, 31(5), 809-815, 201805
- Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung, TRANSLATIONAL LUNG CANCER RESEARCH, 10(2), 766-+, 202102
- Heterogeneous genetic alterations in ovarian mucinous tumors: Application and usefulness of laser capture microdissection, HUMAN PATHOLOGY, 32(11), 1203-1208, 200111
- Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 41(8), 1045-1052, 201708
- Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor, DIAGNOSTICS (BASEL), 12(2), 316-(1-12), 202201
- Idiopathic granulomatous meningoencephalitis presenting as an intracranial tumor, PATHOLOGY INTERNATIONAL, 49(12), 1084-1088, 199912
- Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma, PATHOLOGY INTERNATIONAL, 57(4), 190-199, 200704
- Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21(WAF1), and p27(KIP1) expression in benign, atypical, and anaplastic meningiomas, HUMAN PATHOLOGY, 32(9), 970-975, 200109
- Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival., PATHOBIOLOGY, 86(2-3), 152-161, 201905
- Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT, MEDICINE (Baltimore), 97(32), e11670, 201808
- Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung, PATHOLOGY INTERNATIONAL, 54(7), 486-489, 200407
- Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin, ONCOLOGY LETTERS, 19(6), 4161-4168, 202006
- Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27Kip1., FRONTIERS IN ONCOLOGY, 11, 795467-(1-10), 202201
- Intratumoral Hemorrhage After Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus Caused by Brain Tumors, WORLD NEUROSURGERY, 158, E256-E264, 202202
- Isolated Neurohypophysial Sarcoidosis Involving the Cavernous Sinus Mimicking a Malignant Tumor, NMC CASE REPORT JOURNAL, 9(1), 31-35, 202203
- Long Non-coding RNA LINC00152 Requires EZH2 to Promote Mesothelioma Cell Proliferation, Migration, and Invasion, ANTICANCER RESEARCH, 43(12), 5367-5375, 202312
- Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma, PATHOLOGY INTERNATIONAL, 55(1), 14-18, 200501
- Lymphomas and glioblastomas: Differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3 T, EUROPEAN JOURNAL OF RADIOLOGY, 81(2), 339-344, 201202
- MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung, SCIENTIFIC REPORTS, 8(134), 1-8, 201801
- ★, MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma, MODERN PATHOLOGY, 30(5), 672-681, 201705
- Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma., JOURNAL OF NEUROSURGERY, 122(6), 1370-1379, 201506
- Meningioangiomatosis occurring in a young male without neurofibromatosis - With special reference to its histogenesis and loss of heterozygosity in the NF2 gene region, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 26(1), 125-129, 200201
- Meningioma in mature cystic teratoma of the ovary, PATHOLOGY INTERNATIONAL, 54(7), 543-548, 200407
- Metachronous Double Pituitary Adenoma with Altered Transcriptional Factor Profile: A Case Report and Literature Review, NMC CASE REPORT JOURNAL, 8(1), 657-663, 202110
- Metastatic Malignant Lymphoma Mimicking Cerebral Toxoplasmosis with the "Target Sign", INTERNAL MEDICINE, 58(8), 1157-1162, 201904
- ★, Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation, MODERN PATHOLOGY, 17(6), 705-710, 200406
- Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma., HISTOPATHOLOGY, 74(4), 545-554, 201903
- Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma, PATHOBIOLOGY, 84(2), 99-107, 201702
- Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung, CANCERS, 15(23), 202312
- Myogenic antigen expression is useful for differentiation between epithelioid mesothelioma and non-neoplastic mesothelial cells., HISTOPATHOLOGY, 56(7), 969-974, 201006
- Myxopapillary ependymoma with anaplastic features, PATHOLOGY INTERNATIONAL, 53(10), 700-703, 200310
- Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator, JOURNAL OF NEUROSURGERY, 128(3), 667-678, 201803
- Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines, ONCOLOGY REPORTS, 26(6), 1369-1375, 201109
- PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells, INTERNATIONAL JOURNAL OF ONCOLOGY, 50(3), 1029-1034, 201703
- Perfusion Computed Tomography Parameters Are Useful for Differentiating Glioblastoma, Lymphoma, and Metastasis, WORLD NEUROSURGERY, 119, E890-E897, 201811
- Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature, WORLD NEUROSURGERY, 134, E360-E371, 202002
- Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide., JOURNAL OF NEUROSURGERY, 128(3), 679-684, 201803
- Proton Magnetic Resonance Spectroscopy Detection of High Lipid Levels and Low Apparent Diffusion Coefficient Is Characteristic of Germinomas, WORLD NEUROSURGERY, 112, E84-E94, 201804
- RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging, BRAIN TUMOR PATHOLOGY, 35(1), 41-45, 201801
- Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature, PEDIATRIC NEUROSURGERY, 55(5), 319-325, 202012
- Radiology Profile as a Potential Instrument to Differentiate Between Posterior Fossa Ependymoma (PF-EPN) Group A and B, WORLD NEUROSURGERY, 140, E320-E327, 202008
- Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer., CANCER SCIENCE, 99(8), 1570-1577, 200808
- Reply to 'MUC4 staining in sarcomatoid carcinomas' by Berg et al., MODERN PATHOLOGY, 32(1), 158-158, 201901
- Retrospective immunohistological study of autopsied lungs in patients with acute exacerbation of interstitial pneumonia managed with extracorporeal membrane oxygenation, JOURNAL OF THORACIC DISEASE, 11(11), 4436-4443, 201911
- Role for loss of nuclear PTEN in a harbinger of brain metastases, JOURNAL OF CLINICAL NEUROSCIENCE, 44, 148-154, 201710
- Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions, EUROPEAN JOURNAL OF RADIOLOGY, 74(3), 420-427, 201003
- Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas, EUROPEAN JOURNAL OF RADIOLOGY, 80(2), 412-417, 201111
- SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma from Lung Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 44(9), 1259-1265, 202009
- Sellar Atypical Teratoid/Rhabdoid Tumor (AT/RT): A Clinicopathologically and Genetically Distinct Variant of AT/RT, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 41(7), 932-940, 201707
- Solitary Langerhans cell histiocytosis located in the neurohypophysis with a positive titer HCG-beta in the cerebrospinal fluid, CHILDS NERVOUS SYSTEM, 32(5), 901-904, 201605
- Study of methylation status of p14/ARF gene in benign, atypical, and anaplastic meningiomas by methylation specific PCR, International Congress Series, 1259(C), 13-14, 200402
- T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor, EUROPEAN JOURNAL OF RADIOLOGY, 126, 202005
- TP53 promoter methylation in human gliomas, ACTA NEUROPATHOLOGICA, 110(2), 178-184, 200508
- Trigeminal neuropathy from perineural spread of an amyloidoma detected by blink reflex and thin-slice magnetic resonance imaging, MUSCLE & NERVE, 41(6), 875-878, 201006
- Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia., PATHOBIOLOGY, 83(1), 33-40, 201601
- ★, Utility and pitfall of Immunohistochemistry in the Differential Diagnosis between Epithelioid Mesothelioma and Poorly Differentiated Lung Squamous Cell Carcinoma., HISTOPATHOLOGY, 70(3), 375-384, 201702
- Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia, ONCOLOGY LETTERS, 15(3), 3540-3547, 201803
- Utility of dual-energy CT for predicting the vascularity of meningiomas, EUROPEAN JOURNAL OF RADIOLOGY, 123, 202002
- Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma, HISTOPATHOLOGY, 54(6), 667-676, 200905
- miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV, PATHOBIOLOGY, 90(4), 270-280, 202308
- miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma, FRONTIERS IN ONCOLOGY, 8(446), 1-9, 201810
Invited Lecture, Oral Presentation, Poster Presentation
- O2-48
Knockdown of PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1, AMATYA VISHWA JEET, The 111th Annual Meeting of the Japanese Society of Pathology, 2022/04/14, Without Invitation, English, The Japanese Society of Pathology, Kobe, Japan, experimental
- O3-02 Gene expression microarray analysis of asbestos-related lung cancer in Japanese patients, AMATYA VISHWAJEET, Kishitani Kei, Takeshima Yukio, The 110th Annual Meeting of the Japanese Society of Pathology, 2021/04/22, Without Invitation, English, The Japanese Society of Pathology, Tokyo, experimental
- Alterations of 2p16, 9q33.1 and 19p13 in asbestos-related lung cancer in Japanese patients, AMATYA VISHWA JEET, the 109th Annual Meeting of the Japanese Society of Pathology, 2020/07/01, Without Invitation, English, the Japanese Society of Pathology, Fukuoka, published
- Musashi-1 is novel immunohistochemical marker of neuroendorine carcinoma of lung, 2019/12/06, Without Invitation, English, experimental
- Musashi-1 is a novel immunohistochemical marker of small cell carcinoma of lung, 2019/05/09, Without Invitation, English, experimental
- CM2-3: Exploration of the novel immunohistochemical markers of epithelioid mesothelioma and lung adenocarcinoma, Vishwa Jeet Amatya, Kei Kushitani, Takeshima Yukio, The 64th Autumn Annual Meeting of The Japanese Society of Pathology, 2018/11/23, With Invitation, Japanese, published
- p35: miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma, Rui Suzuki, Vishwa Jeet Amatya, Kei Kushitani, Kai Yuichiro, Kambara Takahiro, Yukio Takeshima, The 64th Autumn Annual Meeting of The Japanese Society of Pathology, 2018/11/22, Without Invitation, Japanese, published
- HGG-21. IMAGING AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF H3 G34R-MUTANT GLIOMAS -A REPORT OF TWO CASES, Shumpei Onishi, Vega Karlowee, Yoshiko Nakano, Manish Kolakshyapati, Takeshi Takayasu, Motoki Takano, Vishwa Jeet Amatya, Yukio Takeshima, Koichi Ichimura, Kazuhiko Sugiyama, Kaoru Kurisu, Fumiyuki Yamasaki, The 18th International Symposium on Pediatric Neuro-Oncology, 2018/06/30, Without Invitation, English, Society for Neuro-Oncology, Colorado, USA, published
- 3-I-16: Glypican-1 is the positive marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, Amatya Vishwa Jeet, Suzuki R, Kai Y, Kushitani K, Miyata Y, Okada M, Takeshima Y, The 107th Annual Meeting of the Japanese Society of Pathology, 2018/06/23, Without Invitation, English, published
- 1-D-15 Utility of Annexin-8 Immunostaining for Differential Diagnosis of Mesothelioma and Lung Cancer, Kushitani K, Amatya Vishwa Jeet, Suzuki R, Kai Y, Takeshima Y., The 107th Annual Meeting of the Japanese Society of Pathology, 2018/06/21, Without Invitation, Japanese, Sapporo, Japan, published
- NIMG-20. ANALYSIS OF PERFUSION CT PARAMETERS FOR DIFFERENTIATING AMONG GLIOBLASTOMA, PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA AND BRAIN METASTASIS, Shumpei Onishi, Yoshinori Kajiwara, Takeshi Takayasu, Manish Kolakshyapati, Minoru Ishifuro, Vishwa Jeet Amatya, Yukio Takeshima, Kazuhiko Sugiyama, Kaoru Kurisu, Fumiyuki Yamasaki, 2017/11/06, Without Invitation, English, Society for Neuro-Oncology, San Francisco, California, published
- Diagnostic utility of MUC4 expression to differentiate epithelioid mesothelioma from lung adenocarcinoma and squamous cell carcinoma, Amatya Vishwa Jeet, Mamas AS, Kushitani K, Kai Y, Miyata Y, Okada M, and Takeshima Y., 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, The International Association for the Study of Lung Cancer (IASLC), Yokohama, Japan, experimental
- Identification of DAB2 and Intelection-1 as novel positive immunohistochemical markers of epithelioid mesothelioma, Kuraoka M., AMATYA VISHWA JEET, Kushitani K., Mawas A.S., Miyata Y., Okada M., Kishimoto T., Inai K., Nishisaka T., Sueda T., and Takeshima Y., 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, The International Association for the Study of Lung Cancer (IASLC), Yokohama, Japan, published
- Usefulness of immunohistochemistry in the differential diagnosis of epithelioid mesothelioma and lung squamous cell carcinoma, Kushitani K., AMATYA VISHWA JEET, Okada Y., Katayama Y., Mawas A.S., Miyata Y., Okada M., Inai K., Kishimoto T, and Takeshima Y., 18th World Conference on Lung Cancer, 2017/10/15, Without Invitation, English, The International Association for the Study of Lung Cancer (IASLC), Yokohama, Japan, preprint
- Sellar atypical teratoid/rhabdoid tumor (AT/RT): A clinicopathologically and genetically distinct variant of AT/RT, Nakata S.; Nobusawa T.; Hirose T; Ito S.; Inoshita N.; Ichi S.; AMATYA VISHWA JEET; Sugiyama K.; Sonoda Y.; Haga H.; Hirato J.; Nakazato Y.; Yokoo H., 3rd Congress of the European Academy of Neurology, 2017/06/24, Without Invitation, English, European Academy of Neurology and the Netherlands Society of Neurology, Amsterdam
- Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway, Karlowee V, Yamasaki F, Amatya Vishwa Jeet, Hirano H, Takayasu T, Nosaka R, Takeshima Y, Sugiyama K, Arita K, Kurisu K., The 35th Annual Meeting of the Japan Society of Brain Tumor Pathology, 2017/05/19, Without Invitation, English, published
- A case of small cell mesothelioma of the pleura, Mayumi Kaneko; Hiroo Matsuura; Hiromi Egawa; Hiroki Kitagawa; Takuhiro Ikeda; Hidenori Mukaida; Vishwa Jeet Amatya; Yukio Takeshima, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, Japanese, experimental
- PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells, Suzuki R, Mawas AS, Miyahara S, Ohoka I, Amatya Vishwa Jeet, Kushitani K, Takeshima Y, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, Japanese, Tokyo, Japan, experimental
- Utility of Intelectin-1 and DAB2 immunostain in distinguishing mesothelioma from lung adenocarcinoma, Kushitani K, Amatya Vishwa Jeet, Miyahara S, Ohoka I, Suzuki R, Mawas AS, Takeshima Y, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, Japanese, experimental
- Differential diagnosis between mesothelioma and reactive mesothelium using immunohistochemistry, Ohoka I, Kushitani K, Amatya Viswa Jeet, Mawas AS, Suzuki R, Miyahara S, Takeshima Y, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, Japanese, Tokyo, Japan, experimental
- MUC4, immunohistochemical marker to differentiate lung adenocarcinoma from epithelioid mesothelioma, Amatya Vishwa Jeet, Kushitani K, Suzuki R, Mawas AS, Takeshima Y, The 106th Annual Meeting of the Japanese Society of Pathology, 2017/04/27, Without Invitation, English, Tokyo, Japan, experimental
- Protein expression profile in acute exacerbation of interstitial pneumonia supported on V-V ECMO, Kida Y, Ohshima S, Kyo M, Amatya Vishwa Jeet, Takeshima Y, Shime N, Society of Critical Care Medicine's 46th Critical Care Congress, 2017/01/21, Without Invitation, English, Honolulu, Hawaii, USA, experimental
- MUC4 is novel markers to differentiate sarcomatoid mesothelioma from sarcomatoid carcinoma of lung., Amatya Vishwa Jeet, Mawas AS, 櫛谷桂, 武島幸男, The 57th Annual Meeting of Japanese Lung Cancer Society, 2016/12/19, Without Invitation, English, experimental
- Clinical implication of High B-value DWI for preoperative differentiation of glioblastoma from itsdifferentials, Kolakshyapati M, Adhikari RB, Takayasu T, Nosaka R, Amatya,Vishwa Jeet, Takeshima Y, Akiyama Y, Sugiyama K, Kurisu K, Yamasaki F, The 21st Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, 2016/11/17, Without Invitation, English, Arizona, USA, experimental
- Immunohistochemical study of multicentric glioma, Vega Karlowee, Amatya Vishwa Jeet,平野宏文,高安武志,野坂亮,Kolakshyapati M,吉廣正子,武島幸男,杉山一彦,有田和徳,栗栖薫,山崎文之, 第30回中国四国脳腫瘍研究会, 2016/09/22, Without Invitation, English, experimental
- Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma, Amatya Vishwa Jeet, Mawas AS, Suzuki R, Kushitani K, Mohi El-Din MM, Takeshima Y., GAP (Global Academic Program) related Meeting Between Hiroshima University and The University of Texas MD Anderson Cancer Center, 2016/07/22, Without Invitation, English, Hiroshima, Japan, experimental
- Gene expression microarray analysis of sarcomatoid mesothelioma and sarcomatoid carcinoma of lung, Amatya Vishwa Jeet, 繰田智之,髙木祐基, Mawas AS,櫛谷 桂,武島幸男, The 105th Annual Meeting of the Japanese Society of Pathology, 2016/05/12, Without Invitation, English, Sendai, Japan, experimental
- Functional analysis of PIM-1 expressions in mesothelioma cell lines, Mawas AS, Amatya Vishwa Jeet,櫛谷 桂,武島幸男, The 105th Annual Meeting of the Japanese Society of Pathology, 2016/05/12, Without Invitation, English, Sendai, Japan, experimental
- MiR-1, MiR-214 reduces cell proliferation and invasion in mesothelioma cells, AMATYA VISHWA JEET, Mawas Amany Sayed, Kei Kushitani, Yukio Takeshima, AMATYA VISHWA JEET, Mawas Amany Sayed, Kei Kushitani, Yukio Takeshima, The 56th Annual Meeting of the Japan Lung Cancer Society, 2015/11/26, Without Invitation, English, The 56th Annual Meeting of the Japan Lung Cancer Society, PACIFICO Yokohama, experimental
- BMET-28 ROLE OF NUCLEAR PTEN IN THE BRAIN METASTASES MECHANISM, Ryo Nosaka, Fumiyuki Yamasaki, Takeshi Takayasu, Vishwa Jeet Amatya, Yukio Takeshima, Kazuhiko Sugiyama, Kaoru Kurisu, 20th Annual Scientific Meeting of the Society for Neuro-Oncology, 2015/11/19, Without Invitation, English, Society for Neuro-Oncology, San Antonio, Texas, published
- MicroRNA profiling of mesothelioma cell lines & their biological function, AMATYA VISHWA JEET, Mawas Amany Sayed, Kei Kushitani, Yukio Takeshima, AMATYA VISHWA JEET, Mawas Amany Sayed, Kei Kushitani, Yukio Takeshima, 2015/10/31, Without Invitation, English, experimental
- Immunohistochemical study of multicentric glioma, 2015/05/29, Without Invitation, English, experimental
- Functional analysis of miR-214 transfection on mesothelioma cell lines, The 104th Annual Meeting of Japanese Society of Pathologists, 2015/04/30, Without Invitation, English, experimental
- Functional role of mir-1, mir-145, and mir-214 in mesothelioma cell proliferation and invasion, The 104th Annual Meeting of Japanese Society of Pathologists, 2015/04/30, Without Invitation, English, experimental
- MiRNA-182, -183 promotes cell growth, invasion, and suppresses apoptosis in mesothelioma cells, AMATYA VISHWA JEET、櫛谷 桂、武島幸男, The 55th Annual Meeting of the Japan Lung Cancer Society, 2014/11/14, Without Invitation, English, experimental
- microRNA profiling and its biological effect on mesothelioma cell lines., Amatya VISHWA JEET, Mawas Amany Sayed、相葉裕幸、櫛谷桂、武島幸男, 2014/10/11, Without Invitation, Japanese, experimental
- MiRNA-182, -183 promotes cell growth, invasion and suppressed apoptosis in mesothelioma cells, AMATYA VISHWA JEET, 2014/04/24, Without Invitation, English, experimental
- CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesotheliom, Aoe K, Amatya Vishwa Jeet, Fujimoto N, Ohnuma K, Hosono O, Hiraki A, Fujii M, Yamada T, Dang NH, Takeshima Y, Inai K, Kishimoto T and Morimoto C, The 11th International Conference of the International Mesothelioma Interest Group, 2012/09/11, Without Invitation, English, Boston, USA, published
- MicroRNA profiling of mesothelioma and mesothelioma-unrelated pleura using taqman array, 2012/04/26, Without Invitation, English, published
- CD9 expression in mesothelioma: A correlation with clinicopathological factors and survival of patients, AMATYA VISHWA JEET, Takeshima Y, Yamada T, Kushitani K, Morimoto C, Inai K, The 10th International Conference of the International Mesothelioma Interest Group, 2010/08/31, Without Invitation, Japanese
- Over expression of CD26/DPP4 in mesothelioma tissue and mesothelioma cell lines, AMATYA VISHWA JEET, Takeshima Y, Yamada T, Kushitani K, Morimoto C, Inai K, The 10th International Conference of the International Mesothelioma Interest Group, 2010/08/21, Without Invitation, Japanese
- Caveolin-1 is a novel immunohistochemical marker of malignant mesothelioma and differentiated epithelioid mesothelioma from lung adenocarcinoma, AMATYA VISHWA JEET, Takeshima Y, Kohno H, Kushitani K, Yamada T, Morimoto C. and Inai K., The 9th International Conference of the International Mesothelioma Interest Group Congress, 2008/09/25, Without Invitation, Japanese, Amsterdam, Netherlands, experimental
- Caveolin-1 is a novel immunohistochemical marker of malignant mesothelioma and differentiated epithelioid mesothelioma from lung adenocarcinoma, AMATYA VISHWA JEET, Takeshima Y, Kohno H, Kushitani K, Yamada T, Morimoto C and Inai K., The 9th International Conference of the International Mesothelioma Interest Group Congress, 2008/09/25, Without Invitation, Japanese, Amsterdam, Netherlands
External Funds
Acceptance Results of Competitive Funds
- KAKENHI, Comprehensive analysis of gene expression in malignant mesothelioma using Affymetrix GeneChip array, 2007, 2008
Social Activities
History as Peer Reviews of Academic Papers
- 2022, Frontiers in Oncology, Molecular and Cellular Oncology, Editor, Associate Editor, 2
- 2022, Case Reports in Pathology, Editor, Editorial Board Member
- 2022, Molecular Medicine Reports, Editor, Editorial Board Member
- 2022, Annals of Clinical Pathology, Editor, Editorial Board Member
- 2022, Internal Medicine Inside, Editor, Editorial Board Member